loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of All Manufacturers & Suppliers for 2480824 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

    Client Virtual Booth
    Menu

    Ipsen

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 CABOZANTINIB (CABOZANTINIB MALATE) (1)

    filter

    01 IPSEN BIOPHARMACEUTICALS CANADA INC (1)

    filter

    01 TABLET (1)

    filter

    01 20MG (1)

    filter

    01 Canada (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag France
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Cabozantinib (cabozantinib Malate)

      PDF Supplier PDF
      URL Supplier Web Content
      TABLET
      20MG
      CABOMETYX
      Canada
      2480824
      30
      Prescription
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for CTD TGA MCC DOSSIER APPLICATION 2480824

      Looking for CTD TGA MCC DOSSIER APPLICATION 2480824 1

      19

      Ipsen, based in France, is a pharmaceutical company.

      One of their notable products is CABOZANTINIB (CABOZANTINIB MALATE), with a corresponding application number 2480824 and regulatory information .

      proudly manufactured in the

      Ipsen's CABOMETYX TABLET, medication with 20MG of CABOZANTINIB (CABOZANTINIB MALATE).

      Post Enquiry
      POST ENQUIRY